Skip to content

Change in AR at other companies

Abbott logo
AbbottABT
$42M-84.0%
Boston Scientific logo
Boston ScientificBSX
$117M+9.3%
IAR
Integra LifeSciencesIART
-$13.65M+36.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$2.96M+225%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$108K-95.8%
AngioDynamics logo
AngioDynamicsANGO
$1.42M+199%

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's change in AR?
ClearPoint Neuro (CLPT) reported change in AR of $2.02M in Q1 2026.
How has ClearPoint Neuro's change in AR changed year-over-year?
ClearPoint Neuro's change in AR increased by 338.7% year-over-year, from -$846K to $2.02M.
What is the long-term trend for ClearPoint Neuro's change in AR?
Over 2 years (2023 to 2025), ClearPoint Neuro's change in AR has grown at a -61.5% compound annual growth rate (CAGR), from $1.8M to $268K.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.